BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38087879)

  • 1. The impact of an additional copy of chromosome 21 in B-cell precursor acute lymphoblastic leukemia.
    Hormann FM; Mooij EJ; van de Mheen M; Beverloo HB; den Boer ML; Boer JM
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23217. PubMed ID: 38087879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel biphenotypic B-cell precursor leukemia cell line (NALM-29) carrying t(9;22)(q34;q11) established from a patient with acute leukemia.
    Matsuo Y; Drexler HG; Takeuchi M; Orita K
    Leuk Res; 1999 Aug; 23(8):731-40. PubMed ID: 10456671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia.
    Schiffman JD; Wang Y; McPherson LA; Welch K; Zhang N; Davis R; Lacayo NJ; Dahl GV; Faham M; Ford JM; Ji HP
    Cancer Genet Cytogenet; 2009 Aug; 193(1):9-18. PubMed ID: 19602459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000.
    Tembhare PR; Ghogale S; Ghatwai N; Badrinath Y; Kunder N; Patkar NV; Bibi AR; Chatterjee G; Arora B; Narula G; Banawali S; Deshpande N; Amare P; Gujral S; Subramanian PG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):100-111. PubMed ID: 27718302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of microRNAs in glucocorticoid‑resistant B‑cell precursor acute lymphoblastic leukemia.
    Sakurai N; Komada Y; Hanaki R; Morimoto M; Ito T; Nakato D; Hirayama M
    Oncol Rep; 2019 Aug; 42(2):708-716. PubMed ID: 31233193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.
    Rand V; Parker H; Russell LJ; Schwab C; Ensor H; Irving J; Jones L; Masic D; Minto L; Morrison H; Ryan S; Robinson H; Sinclair P; Moorman AV; Strefford JC; Harrison CJ
    Blood; 2011 Jun; 117(25):6848-55. PubMed ID: 21527530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
    Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.
    Schwab CJ; Chilton L; Morrison H; Jones L; Al-Shehhi H; Erhorn A; Russell LJ; Moorman AV; Harrison CJ
    Haematologica; 2013 Jul; 98(7):1081-8. PubMed ID: 23508010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
    Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
    Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Zaliova M; Potuckova E; Hovorkova L; Musilova A; Winkowska L; Fiser K; Stuchly J; Mejstrikova E; Starkova J; Zuna J; Stary J; Trka J
    Haematologica; 2019 Jul; 104(7):1407-1416. PubMed ID: 30630977
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
    Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
    Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative genomic analysis of B-lymphoblastic lymphoma with intrachromosomal amplification of chromosome 21.
    Sharma R; Klairmont MM; Holland AC; Choi JK; Mullighan CG; Wang L; Sandlund JT; Pui CH; Inaba H
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28357. PubMed ID: 32469139
    [No Abstract]   [Full Text] [Related]  

  • 13. SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.
    Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B
    Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel B-cell precursor leukemia sister cell lines, NALM-33 and NALM-34, established from a patient with acute lymphoblastic leukemia.
    Matsuo Y; Drexler HG; Takeuchi M; Orita K
    Leuk Lymphoma; 1999 Nov; 35(5-6):513-26. PubMed ID: 10609789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal?
    Tsuchiya KD; Davis B; Gardner RA
    Cancer Genet; 2017 Dec; 218-219():10-14. PubMed ID: 29153092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines.
    Kim DH; Moldwin RL; Vignon C; Bohlander SK; Suto Y; Giordano L; Gupta R; Fears S; Nucifora G; Rowley JD
    Blood; 1996 Aug; 88(3):785-94. PubMed ID: 8704231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL.
    Wrona E; Braun M; Pastorczak A; Taha J; Lejman M; Kowalczyk J; Fendler W; Młynarski W
    J Appl Genet; 2019 Nov; 60(3-4):347-355. PubMed ID: 31456164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21.
    Verdoni AM; Zilla ML; Bullock G; Guinipero TL; Meade J; Yatsenko SA
    Am J Med Genet A; 2022 Aug; 188(8):2325-2330. PubMed ID: 35678493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia.
    Schwab CJ; Jones LR; Morrison H; Ryan SL; Yigittop H; Schouten JP; Harrison CJ
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1104-13. PubMed ID: 20815030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.